表紙
市場調查報告書

T細胞急性淋巴性白血病的全球市場規模:產業分析,佔有率,成長,趨勢,預測(2019年∼2026年)

Global T-Cell Acute Lymphoblastic Leukemia Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版商 Value Market Research 商品編碼 929209
出版日期 內容資訊 英文 105 Pages
商品交期: 最快1-2個工作天內
價格
T細胞急性淋巴性白血病的全球市場規模:產業分析,佔有率,成長,趨勢,預測(2019年∼2026年) Global T-Cell Acute Lymphoblastic Leukemia Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
出版日期: 2020年03月01日內容資訊: 英文 105 Pages
簡介

全球T細胞急性淋巴性白血病市場從2020年到2026年的預測期間內將與過去數年一樣顯著增長。

本報告提供全球T細胞急性淋巴性白血病市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各類型·治療·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 報告概要
  • 調查範圍
  • 調查手法

第2章 摘要整理

  • 市場概況
  • 市場概述

第3章 產業分析

  • 簡介
  • 市場成長要素
  • 阻礙市場要素
  • 市場機會
  • 市場趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 市場分析:各類型

  • 概要
  • 市場分析
  • B細胞
  • T細胞

第6章 市場分析:不同治療

  • 概要
  • 市場分析
  • 化學放射線治療
  • 骨髓移植
  • 目標療法
  • 免疫療法

第7章 市場分析:各終端用戶

  • 概要
  • 市場分析
  • 醫院
  • 診療所
  • 其他

第8章 市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 競爭情形

  • 市場競爭
  • 聯盟/合作/契約
  • 合併·收購
  • 新產品的銷售
  • 其他開發

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中率
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • CELGENE CORPORATION
  • Erytech Pharma Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Spectrum Pharmaceuticals, Inc.
目錄

Value Market Research's latest report on the Global T-Cell Acute Lymphoblastic Leukemia Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global t-cell acute lymphoblastic leukemia market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global t-cell acute lymphoblastic leukemia market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global t-cell acute lymphoblastic leukemia market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global t-cell acute lymphoblastic leukemia market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global t-cell acute lymphoblastic leukemia market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global t-cell acute lymphoblastic leukemia market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global t-cell acute lymphoblastic leukemia market.

The market analysis involves a section exclusively to list the major players of the global t-cell acute lymphoblastic leukemia market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The T-Cell Acute Lymphoblastic Leukemia Market Report Segments the market as below:

By Type

  • B-Cell
  • T-Cell

By Treatment

  • ChemotherapyRadiation
  • TherapyBone
  • Marrow Transplant
  • Targeted Therapy
  • Immunotherapy

By End-User

  • Hospitals
  • Clinics
  • Others

Table of Contents

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of T-Cell Acute Lymphoblastic Leukemia Market
  • 2.2. Global T-Cell Acute Lymphoblastic Leukemia Market Snapshot

3 . T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of T-Cell Acute Lymphoblastic Leukemia Market
  • 3.3. Market Restraints of T-Cell Acute Lymphoblastic Leukemia Market
  • 3.4. Opportunities of T-Cell Acute Lymphoblastic Leukemia Market
  • 3.5. Trends of T-Cell Acute Lymphoblastic Leukemia Market
  • 3.6. Porter's Five Force Analysis of T-Cell Acute Lymphoblastic Leukemia Market
  • 3.7. T-Cell Acute Lymphoblastic Leukemia Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Type
    • 3.7.2 Market Attractive Analysis by Treatment
    • 3.7.3 Market Attractive Analysis by End-User
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. T-Cell Acute Lymphoblastic Leukemia Value Chain Analysis
  • 4.2. T-Cell Acute Lymphoblastic Leukemia Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. T-Cell Acute Lymphoblastic Leukemia Raw Material Manufactures List
    • 4.2.3. Price Trend of T-Cell Acute Lymphoblastic Leukemia Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type
  • 5.3 Market Analysis of B-Cell by Regions
  • 5.4 Market Analysis of T-Cell by Regions

6 . GLOBAL T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA MARKET ANALYSIS BY TREATMENT

  • 6.1 Overview by Treatment
  • 6.2 Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Treatment
  • 6.3 Market Analysis of Chemotherapy
Radiation by Regions
  • 6.4 Market Analysis of Therapy
Bone by Regions
  • 6.5 Market Analysis of Marrow Transplant by Regions
  • 6.6 Market Analysis of Targeted Therapy by Regions
  • 6.7 Market Analysis of Immunotherapy by Regions

7 . GLOBAL T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by End-User
  • 7.3 Market Analysis of Hospitals by Regions
  • 7.4 Market Analysis of Clinics by Regions
  • 7.5 Market Analysis of Others by Regions

8 . GLOBAL T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by Market Segment
    • 8.4.3. Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by Market Segment
    • 8.5.3. Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Market Segment
    • 8.6.3. Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA COMPANIES

  • 9.1. T-Cell Acute Lymphoblastic Leukemia Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Amgen, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Bristol-Myers Squibb Company
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. CELGENE CORPORATION
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Erytech Pharma Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Novartis AG
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Pfizer, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Sanofi
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Spectrum Pharmaceuticals, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies.

LIST OF TABLES

  • Global T-Cell Acute Lymphoblastic Leukemia Market Snapshot
  • Drivers of The Global T-Cell Acute Lymphoblastic Leukemia Market Impact Analysis
  • Restraints of The Global T-Cell Acute Lymphoblastic Leukemia Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in B-Cell by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in T-Cell by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Treatment (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Chemotherapy
Radiation by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Therapy
Bone by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Marrow Transplant by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Targeted Therapy by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Immunotherapy by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by End-User (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Hospitals by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Clinics by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Others by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market by Geography (USD MN)
  • North America T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country (USD MN)
  • United State T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • United State T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • United State T-Cell Acute Lymphoblastic Leukemia Market Analysis by End-User (USD MN)
  • Rest of North America T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Rest of North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Rest of North America T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User(USD MN)
  • Europe T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by 38 (USD MN)
  • United Kingdom T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • United Kingdom T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • United Kingdom T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • France T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • France T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • France T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Germany T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Germany T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Germany T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Rest of Europe T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Rest of Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Rest of Europe T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country (USD MN)
  • China T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • China T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • China T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Japan T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Japan T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Japan T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • India T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • India T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • India T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Rest of Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Rest of Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Rest of Asia Pacific T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Latin America T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country (USD MN)
  • Brazil T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Brazil T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Brazil T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Rest of Latin America T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Rest of Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Rest of Latin America T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by Country (USD MN)
  • Middle East T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Middle East T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Middle East T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Africa T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by Treatment (USD MN)
  • Africa T-Cell Acute Lymphoblastic Leukemia Market Estimate by End-User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of T-Cell Acute Lymphoblastic Leukemia Report
  • Market Research Process
  • Market Research Methodology
  • Global T-Cell Acute Lymphoblastic Leukemia Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Type (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in B-Cell by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in T-Cell by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by Treatment (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Chemotherapy
Radiation by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Therapy
Bone by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Marrow Transplant by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Targeted Therapy by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Immunotherapy by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis by End-User (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Hospitals by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Clinics by Geography (USD MN)
  • Global T-Cell Acute Lymphoblastic Leukemia Market Analysis in Others by Geography (USD MN)
  • Latin America T-Cell Acute Lymphoblastic Leukemia Market by Revenue
  • Middle East & Africa T-Cell Acute Lymphoblastic Leukemia Market by Revenue
  • Recent Development in T-Cell Acute Lymphoblastic Leukemia Industry
  • Company Market Share Analysis, 2019

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.